Peptide record

TPDB92318

MC–FA Antibacterial Anticancer Antifungal Antiparasitic modified_plain modified
27 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92318
MC–FA
Antibacterial Anticancer Antifungal Antiparasitic
Anti-infective peptides Cancer-related peptides
Peptipedia CancerPPD 2.0
modified_plain
Yes
A 27-aa modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from Peptipedia and CancerPPD 2.0, with an available 3D structural model.
C-terminal: Folic Acid
Sequence
GIGAVLKVLTTGLPALISWIKRKRQQC
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
27 reviewed residue count
Folic Acid Activity
L Activity
Linear Activity
Free Activity
Anticancer Antibacterial Activity
Synthetic analogue Activity
Evidence Records 3 records
Evidence 1 Activity

Activity

IC50
IC50 = 66.43 µg/mL
Anticancer
66.43 µg/mL

Target

Cervical Cancer
HeLa
Cervix

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 35.22 µg/ mL
Anticancer
35.22

Target

Cervical Cancer
C-33A
Cervix

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023
Evidence 3 Activity

Activity

IC50
IC50 = 12.63 µg/mL
Anticancer
12.63 µg/mL

Target

Breast Cancer
MCF-7
Breast

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023